Horizon Space Acquisition and ArcheNova Biotech Announce Merger
Horizon Space Acquisition (HSPOF) has entered into a definitive business combination agreement with ArcheNova Biotech to form ArcheNova Technology, which will be listed on the Nasdaq. The merger is expected to create a publicly traded entity focused on biotechnology and related innovations. The new company will operate under the leadership of Dr., who brings extensive experience in the field. This strategic move aims to leverage Horizon's expertise in SPAC transactions with ArcheNova Biotech’s scientific capabilities, positioning it for growth in the healthcare sector.
Topics: Mergers & Acquisitions SPACs